We are live on ! Find out more
AC

Ayrton Capital Portfolio holdings

AUM $14.7M Turnover 17.5%
1-Year Est. Return 12.82%
This Fund
S&P 500
This Quarter Est. Return
-2.18%
1 Year Est. Return
-12.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.7M
AUM Growth
-$1.27M
Cap. Flow
-$10.5M
Cap. Flow %
-70.86%
Top 10 Hldgs %
87.65%
Holding
80
New
6
Increased
3
Reduced
2
Closed
8
Avg Time Held
1.2 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.5 years

Top Buys

Rank Stock Value
1
CREX icon
Creative Realities
CREX
+$647K
2
PAVM icon
PAVmed
PAVM
+$618K
3
TBLT icon
ToughBuilt Industries, Inc. Common Stock
TBLT
+$322K
4
DCFC
Tritium DCFC Limited Ordinary Shares
DCFC
+$260K
5
ATXG icon
Addentax Group
ATXG
+$242K

Top Sells

Rank Stock Value
1
BTM icon
Bitcoin Depot
BTM
+$1.05M
2
PMCB icon
PharmaCyte Biotech
PMCB
+$471K
3
EUDA icon
EUDA Health Holdings
EUDA
+$359K
4
POL.WS
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
+$130K
5
KSCP icon
Knightscope
KSCP
+$67.9K

Sector Composition

Rank Sector Weight
1 Miscellaneous 72.08%
2 Healthcare 12.88%
3 Financials 7.37%
4 Technology 3.29%
5 Industrials 2.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SHFS icon
1
SHF Holdings
SHFS
$148K
$931K 6.31%
4,909
– –
2022 Q2
5 quarters
OTEC
2
DELISTED
OceanTech Acquisitions I Corp. Class A Common Stock
OTEC
$771K 5.23%
70,000
– –
2021 Q4
7 quarters
PAVM icon
3
PAVmed
PAVM
$19.3M
$661K 4.48%
4,987
+3,988
+399% +$618K
2023 Q1
2 quarters
CREX icon
4
Creative Realities
CREX
$29.1M
$398K 2.7%
+256,584
New +$647K
2023 Q3
0 quarters
TBLT icon
5
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$219K 1.49%
+17,286
New +$322K
2023 Q3
0 quarters
PMCB icon
6
PharmaCyte Biotech
PMCB
$3.65M
$193K 1.31%
92,087
-184,905
-67% -$471K
2021 Q4
7 quarters
RCON icon
7
Recon Technology
RCON
$20M
$176K 1.2%
158
– –
2023 Q1
2 quarters
ATXG icon
8
Addentax Group
ATXG
$4.78M
$161K 1.1%
7,975
+5,773
+262% +$242K
2023 Q2
1 quarter
PEPL
9
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
$141K 0.95%
13,028
– –
2022 Q1
6 quarters
SHPH icon
10
Shuttle Pharmaceuticals
SHPH
$24.2M
$134K 0.91%
110
-15
-12% -$24.7K
2023 Q2
1 quarter
AUUD icon
11
Auddia
AUUD
$5.66M
$87.6K 0.59%
74
– –
2023 Q2
1 quarter
LUCD icon
12
Lucid Diagnostics
LUCD
$91.3M
$86.5K 0.59%
+73,907
New +$107K
2023 Q3
0 quarters
DCFC
13
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
$82.9K 0.56%
+1,368
New +$260K
2023 Q3
0 quarters
OPFI.WS icon
14
DELISTED
OppFi Inc Warrants
OPFI.WS
$63K 0.43%
25,000
– –
2021 Q4
7 quarters
OCEA icon
15
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
$52K 0.35%
+13,345
New +$61.3K
2023 Q3
0 quarters
SOC.WS icon
16
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$46.3K 0.31%
57,836
– –
2021 Q4
7 quarters
SKYAW icon
17
SkyAI Inc
SKYAW
$582K
$24.8K 0.17%
235,200
– –
2022 Q2
5 quarters
LUCYW icon
18
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$50.2K
$22.6K 0.15%
150,900
– –
2022 Q3
4 quarters
ZIVOW
19
DELISTED
Zivo Bioscience, Inc. Warrants
ZIVOW
$21.9K 0.15%
48,850
– –
2021 Q4
7 quarters
WKSPW icon
20
DELISTED
Worksport, Ltd. Warrant
WKSPW
$21.5K 0.15%
86,020
– –
2021 Q4
7 quarters
ACAXR
21
DELISTED
Alset Capital Acquisition Corp Right
ACAXR
$21K 0.14%
100,000
– –
2022 Q2
5 quarters
BTMWW
22
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
$19K 0.13%
100,000
– –
2022 Q2
5 quarters
NLSPW icon
23
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$17.9K 0.12%
170,100
– –
2021 Q4
7 quarters
FEXDR icon
24
DELISTED
Fintech Ecosystem Development Corp. Right
FEXDR
$17.5K 0.12%
125,000
– –
2022 Q1
6 quarters
AAC.WS
25
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$16.4K 0.11%
24,851
– –
2021 Q4
7 quarters
1
2 3

Similar funds

VVA
Vintage Ventures Advisors Herzliya, Israel $15.2M AUM 35.41% 1-Year Est. Return
AR
Acacia Research New York $14.1M AUM 50.98% 1-Year Est. Return
TAM
Toscafund Asset Management London, United Kingdom $15.6M AUM 12.56% 1-Year Est. Return
RCGI
Ribbit Capital GP IV Palo Alto, California $15.6M AUM 103.62% 1-Year Est. Return
AEM
ACON Equity Management Washington, District of Columbia $13.8M AUM 62.17% 1-Year Est. Return
CAM
Connacht Asset Management New York $16.9M AUM 40.41% 1-Year Est. Return
HMP9
Highland Management Partners 9 Cambridge, Massachusetts $12.6M AUM 85.13% 1-Year Est. Return
LM
Lockheed Martin Bethesda, Maryland $12.1M AUM 46.13% 1-Year Est. Return

Ayrton Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Ayrton Capital held 80 positions worth $14.7M, down 7.9% from $16M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Ayrton Capital withdrew a net $10.5M in Q3 2023, closing 8 positions and reducing 2 holdings. Its most notable exit was Bitcoin Depot, an estimated $1.05M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 72% of assets, up from 70% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ayrton Capital opened a new position in Creative Realities worth $398K.

  • Ayrton Capital's largest Q3 2023 buy was Creative Realities: 256,584 shares worth $398K.
  • Ayrton Capital added most to PAVmed in Q3 2023, an estimated $618K increase.
  • Ayrton Capital's biggest Q3 2023 reduction was PharmaCyte Biotech, cutting an estimated $471K.
  • Ayrton Capital fully exited Bitcoin Depot in Q3 2023, selling an estimated $1.05M.
  • Ayrton Capital's ten largest holdings make up 88% of its $14.7M portfolio in Q3 2023.
  • Ayrton Capital opened 6 new positions and closed 8 in Q3 2023.
  • Ayrton Capital's portfolio value fell 7.9% quarter-over-quarter to $14.7M.

Based on Ayrton Capital's 13F filing for Q3 2023, filed 13 Nov 2023.